Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

OBJECTIVES: The objective of this study was to contribute long-term safety data for infliximab and other therapies in Crohn's disease (CD). METHODS: We prospectively evaluated CD patients enrolled in the large, observational Crohn's Therapy, Resource, Evaluation, and Assessment Tool regist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lichtenstein, Gary R, Feagan, Brian G, Cohen, Russell D, Salzberg, Bruce A, Diamond, Robert H, Price, Samiyeh, Langholff, Wayne, Londhe, Anil, Sandborn, William J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2012
Matèries:
Inflammatory Bowel Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438468/
https://ncbi.nlm.nih.gov/pubmed/22890223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2012.218
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars